New therapeutic target identified for ALS and frontotemporal degeneration

A team of scientists led by researchers from the University of California, San Diego School of Medicine and Ludwig Institute for Cancer Research have identified a novel therapeutic approach for the most frequent genetic cause of ALS, a disorder of the regions of the brain and spinal cord that control voluntary muscle movement, and frontal temporal degeneration, the second most frequent dementia.

Fuente : http://www.eurekalert.org/pub_releases/2013-11/uoc…